|
Market Cap (4-Jun) $4,960,185 (1,007th) |
Close (30-Jun) $0.038 |
Volume (30-Jun) 1,963,571 |
Shortsold (11-May) 1 (0.00%) (717th) |
|
52w High $0.60 |
52w Low $0.083 |
P/E - |
EPS -0.84 |
CHM released this announcement to the ASX on 22 November 2021, 9:35. The announcement is not marked as price sensitive, and is 18 page(s) in length and 1.81MB in size.
You can view all announcements from CHM and see how they appear on a price chart on the announcements page.
At the date of this announcement, CHM was 0.290% short sold according to ASIC data. It was ranked the 353rd most shorted stock on the ASX. It remains ranked 717th as of the latest reported data (11 May 2026).
| Other Recent Announcements from CHM | |
|---|---|
| Notice under section 708A | 29 June 2023, 15:34 |
| Application for quotation of securities - CHM | 29 June 2023, 15:29 |
| Results of Extraordinary General Meeting | 29 June 2023, 11:42 |
| AGM Presentation | 22 November 2021, 9:35 |
| CLTX CAR T data shows regional control of tumour recurrence | 22 November 2021, 9:15 |
| CLTX CAR T PRESENTS POSITIVE INITIAL PHASE 1 CLINICAL DATA | 15 November 2021, 8:52 |
| FIRST MILESTONE ON PATH TO CDH17 CAR T CLINICAL TRIAL | 22 October 2021, 9:15 |
You must be logged in to post a reply.
Chimeric Therapeutics Ltd 